{"id":400261,"date":"2020-12-15T12:38:09","date_gmt":"2020-12-15T17:38:09","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=400261"},"modified":"2020-12-15T12:38:09","modified_gmt":"2020-12-15T17:38:09","slug":"prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/","title":{"rendered":"Prevail Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Prevail Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 PRVL"},"content":{"rendered":"

<\/p>\n

Prevail Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Prevail Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 PRVL<\/b><\/p>\n

NEW YORK–(BUSINESS WIRE<\/a>)–
\nHalper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Prevail Therapeutics Inc. (NASDAQ: PRVL) to Eli Lilly and Company is fair to Prevail shareholders. Under the terms of the merger agreement, Prevail shareholders will receive $22.50 per share in cash plus one non-tradable contingent value right worth up to $4.00 per share in cash.\n<\/p>\n

\nHalper Sadeh encourages Prevail shareholders to click here to learn more about their legal rights and options<\/a><\/b> or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com<\/a> or zhalper@halpersadeh.com<\/a>.\n<\/p>\n

\nThe investigation concerns whether Prevail and its board of directors violated the federal securities laws and\/or breached their fiduciary duties to shareholders by failing to: (1) obtain the best possible price for Prevail shareholders; (2) determine whether Eli Lilly is underpaying for Prevail; and (3) disclose all material information necessary for Prevail shareholders to adequately assess and value the merger consideration. On behalf of Prevail shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.\n<\/p>\n

\nHalper Sadeh encourages Prevail shareholders to click here to learn more about their legal rights and options<\/a><\/b> or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com<\/a> or zhalper@halpersadeh.com<\/a>.\n<\/p>\n

\nHalper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.\n<\/p>\n

\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20201215005965\/en\/<\/a><\/span><\/p>\n

\nHalper Sadeh LLP
\n
Daniel Sadeh, Esq.
\n
Zachary Halper, Esq.
\n
(212) 763-0060
\n
sadeh@halpersadeh.com
\n<\/a>
zhalper@halpersadeh.com
\n<\/a>
https:\/\/www.halpersadeh.com<\/a><\/p>\n

KEYWORDS:<\/b> New York United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Legal Professional Services<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Prevail Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Prevail Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 PRVL NEW YORK–(BUSINESS WIRE)– Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Prevail Therapeutics Inc. (NASDAQ: PRVL) to Eli Lilly and Company is fair to Prevail shareholders. Under the terms of the merger agreement, Prevail shareholders will receive $22.50 per share in cash plus one non-tradable contingent value right worth up to $4.00 per share in cash. Halper Sadeh encourages Prevail shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or … <\/p>\n

Continue reading “Prevail Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Prevail Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 PRVL”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-400261","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nPrevail Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Prevail Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 PRVL - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prevail Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Prevail Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 PRVL - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Prevail Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Prevail Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 PRVL NEW YORK–(BUSINESS WIRE)– Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Prevail Therapeutics Inc. (NASDAQ: PRVL) to Eli Lilly and Company is fair to Prevail shareholders. Under the terms of the merger agreement, Prevail shareholders will receive $22.50 per share in cash plus one non-tradable contingent value right worth up to $4.00 per share in cash. Halper Sadeh encourages Prevail shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or … Continue reading "Prevail Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Prevail Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 PRVL"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-15T17:38:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201215005965r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Prevail Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Prevail Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 PRVL\",\"datePublished\":\"2020-12-15T17:38:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/\"},\"wordCount\":368,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201215005965r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/\",\"name\":\"Prevail Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Prevail Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 PRVL - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201215005965r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2020-12-15T17:38:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201215005965r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201215005965r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prevail Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Prevail Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 PRVL\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prevail Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Prevail Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 PRVL - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/","og_locale":"en_US","og_type":"article","og_title":"Prevail Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Prevail Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 PRVL - Market Newsdesk","og_description":"Prevail Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Prevail Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 PRVL NEW YORK–(BUSINESS WIRE)– Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Prevail Therapeutics Inc. (NASDAQ: PRVL) to Eli Lilly and Company is fair to Prevail shareholders. Under the terms of the merger agreement, Prevail shareholders will receive $22.50 per share in cash plus one non-tradable contingent value right worth up to $4.00 per share in cash. Halper Sadeh encourages Prevail shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or … Continue reading \"Prevail Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Prevail Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 PRVL\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-15T17:38:09+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201215005965r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Prevail Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Prevail Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 PRVL","datePublished":"2020-12-15T17:38:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/"},"wordCount":368,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201215005965r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/","name":"Prevail Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Prevail Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 PRVL - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201215005965r1&sid=flmnd&distro=nx&lang=en","datePublished":"2020-12-15T17:38:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201215005965r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201215005965r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-prevail-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Prevail Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Prevail Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 PRVL"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/400261","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=400261"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/400261\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=400261"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=400261"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=400261"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}